Skip to content
2000
Volume 33, Issue 8
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background

Mitochondria are the main sites of cellular aerobic energy production through conjugation of respiration and oxidative phosphorylation. We have recently discovered mutations (genome variants) of mitochondrial DNA (mtDNA) associated with atherosclerosis. We have then investigated the possible mechanisms underlying such association and the role of mitochondrial mutations in atherogenesis. Mitochondrial dysfunction is a known component of the pathogenesis of chronic human diseases, including atherosclerosis.

Objective

The aim of the study was to explore whether there is a relationship between cellular oxygen consumption and atherosclerosis-associated mitochondrial mutations. The study of mitochondrial respiration abnormalities can help to understand the role of mtDNA mutations in pathology.

Methods

By using the polarographic method with Clark electrode, we tested the possibility of respiration impairment in permeabilized cells carrying the tested mtDNA variants using the cybrid (cytoplasmic hybrid) lines. Mitochondria introduced in the cybrid lines were obtained from atherosclerotic patients that differed in the profile of mtDNA mutations, which made it possible to compare the degree of mtDNA mutation load with the rate of oxygen consumption by cybrid cells.

Results

It was found that three of the studied mutations were individually associated with impaired respiration. Besides, some combinations of two specific mutations have a high probability of being associated with altered oxygen consumption. As a result, eight mutations were identified, individually or paired combinations of which were associated with high or low rates of cellular respiration, significantly different from control cells.

Conclusion

The observed effect may be involved in the pathogenesis of atherosclerosis. The study of mtDNA mutations associated with atherosclerosis can help reveal pharmacological targets for the development of novel therapies.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673302002240605092523
2024-06-14
2026-03-11
Loading full text...

Full text loading...

References

  1. RossmannM.P. DuboisS.M. AgarwalS. ZonL.I. Mitochondrial function in development and disease.Dis. Model. Mech.2021146dmm04891210.1242/dmm.04891234114603
    [Google Scholar]
  2. LoureiroR. MesquitaK.A. Magalhães-NovaisS. OliveiraP.J. Vega-NaredoI. Mitochondrial biology in cancer stem cells.Semin. Cancer Biol.201747182810.1016/j.semcancer.2017.06.01228673608
    [Google Scholar]
  3. RutterG.A. BurnettP. Robb-GaspersL.D. ThomasA.P. DentonR.M. GriffithsE.J. RizzutoR. Mitochondrial Ca2+ Signalling.Integrative Aspects of Calcium Signalling. VerkhratskyA. ToescuE.C. SpringerBoston, MA199810.1007/978‑1‑4899‑1901‑4_9
    [Google Scholar]
  4. FoxT.D. Mitochondrial protein synthesis, import, and assembly.Genetics201219241203123410.1534/genetics.112.14126723212899
    [Google Scholar]
  5. TaanmanJ.W. The mitochondrial genome: structure, transcription, translation and replication.Biochim. Biophys. Acta Bioenerg.19991410210312310.1016/S0005‑2728(98)00161‑310076021
    [Google Scholar]
  6. KimH.R. WonS.J. FabianC. KangM.G. SzardeningsM. ShinM.G. Mitochondrial DNA aberrations and pathophysiological implications in hematopoietic diseases, chronic inflammatory diseases, and cancers.Ann. Lab. Med.201535111410.3343/alm.2015.35.1.125553274
    [Google Scholar]
  7. KazakL. ReyesA. HoltI.J. Minimizing the damage: repair pathways keep mitochondrial DNA intact.Nat. Rev. Mol. Cell Biol.2012131065967110.1038/nrm343922992591
    [Google Scholar]
  8. SazonovaM.A. SinyovV.V. RyzhkovaA.I. GalitsynaE.V. KhasanovaZ.B. PostnovA.Y. YaryginaE.I. OrekhovA.N. SobeninI.A. Role of mitochondrial genome mutations in pathogenesis of carotid atherosclerosis.Oxid. Med. Cell. Longev.201720171710.1155/2017/693439428951770
    [Google Scholar]
  9. SobeninI. ZhelankinA. MitrofanovK. SinyovV. SazonovaM. PostnovA. OrekhovA. Mutations of mitochondrial DNA in atherosclerosis and atherosclerosis-related diseases.Curr. Pharm. Des.20152191158116310.2174/138161282066614101313300025312735
    [Google Scholar]
  10. SobeninI.A. SazonovaM.A. PostnovA.Y. SalonenJ.T. BobryshevY.V. OrekhovA.N. Association of mitochondrial genetic variation with carotid atherosclerosis.PLoS One201387e6807010.1371/journal.pone.006807023874496
    [Google Scholar]
  11. DingY. XiaB.H. ZhangC.J. ZhuoG.C. Mitochondrial tRNALeu(UUR) C3275T, tRNAGln T4363C and tRNALys A8343G mutations may be associated with PCOS and metabolic syndrome.Gene201864229930610.1016/j.gene.2017.11.04929155328
    [Google Scholar]
  12. MengF. JiaZ. ZhengJ. JiY. WangJ. XiaoY. FuY. WangM. LingF. GuanM.X. A deafness-associated mitochondrial DNA mutation caused pleiotropic effects on DNA replication and tRNA metabolism.Nucleic Acids Res.202250169453946910.1093/nar/gkac72036039763
    [Google Scholar]
  13. ChungC.Y. SinghK. KotiadisV.N. ValdebenitoG.E. AhnJ.H. TopleyE. TanJ. AndrewsW.D. BilangesB. PitceathlyR.D.S. SzabadkaiG. YunevaM. DuchenM.R. Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation.Nat. Commun.2021121640910.1038/s41467‑021‑26746‑234737295
    [Google Scholar]
  14. Gutiérrez CortésN. PertuisetC. DumonE. BörlinM. Da CostaB. Le GuédardM. StojkovicT. LoundonN. RouillonI. NadjarY. LetellierT. JonardL. MarlinS. RocherC. Mutation m.3395A > G in MT-ND1 leads to variable pathologic manifestations.Hum. Mol. Genet.202029698098910.1093/hmg/ddaa02032011699
    [Google Scholar]
  15. Galera-MongeT. Zurita-DíazF. CanalsI. Grønning HansenM. Rufián-VázquezL. EhingerJ.K. ElmérE. MartinM.A. GaresseR. AhleniusH. GallardoM.E. Mitochondrial dysfunction and calcium dysregulation in leigh syndrome induced pluripotent stem cell derived neurons.Int. J. Mol. Sci.2020219319110.3390/ijms2109319132366037
    [Google Scholar]
  16. YuX. JiK. LinY. XuX. WangW. LiY. LuJ.Q. ZhaoY. YanC. Leber hereditary optic neuropathy and dystonia overlapping mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes due to m.14459G>A mutation.Neurol. Sci.202142125123513010.1007/s10072‑021‑05155‑933779865
    [Google Scholar]
  17. TuppenH.A.L. BlakelyE.L. TurnbullD.M. TaylorR.W. Mitochondrial DNA mutations and human disease.Biochim. Biophys. Acta Bioenerg.20101797211312810.1016/j.bbabio.2009.09.00519761752
    [Google Scholar]
  18. LenazG. BaraccaA. BarberoG. BergaminiC. DalmonteM.E. Del SoleM. FaccioliM. FalascaA. FatoR. GenovaM.L. SgarbiG. SolainiG. Mitochondrial respiratory chain super-complex I-III in physiology and pathology.Biochim. Biophys. Acta.20101797(6-7)63364010.1016/j.bbabio.2010.01.025
    [Google Scholar]
  19. CaruanaN.J. StroudD.A. The road to the structure of the mitochondrial respiratory chain supercomplex.Biochem. Soc. Trans.202048262162910.1042/BST2019093032311046
    [Google Scholar]
  20. RyyttyS. ModiS.R. NaumenkoN. ShakirzyanovaA. RahmanM.O. VaaraM. SuomalainenA. TaviP. HämäläinenR.H. Varied responses to a high m.3243A>G mutation load and respiratory chain dysfunction in patient-derived cardiomyocytes.Cells20221116259310.3390/cells1116259336010669
    [Google Scholar]
  21. XuM. KopajtichR. ElstnerM. LiH. LiuZ. WangJ. ProkischH. FangF. Identification of a novel m.3955G>A variant in MT-ND1 associated with Leigh syndrome.Mitochondrion202262132310.1016/j.mito.2021.10.00234656796
    [Google Scholar]
  22. RenH. LinY. LiY. ZhangX. WangW. XuX. JiK. ZhaoY. YanC. Leber’s hereditary optic neuropathy plus dystonia caused by the mitochondrial ND1 gene m.4160T>C mutation.Neurol. Sci.20224395581559210.1007/s10072‑022‑06165‑x35699829
    [Google Scholar]
  23. JiY. ZhangJ. LuY. YiQ. ChenM. XieS. MaoX. XiaoY. MengF. ZhangM. YangR. GuanM.X. Complex I mutations synergize to worsen the phenotypic expression of Leber’s hereditary optic neuropathy.J. Biol. Chem.202029538132241323810.1074/jbc.RA120.01460332723871
    [Google Scholar]
  24. KishitaY. IshikawaK. NakadaK. HayashiJ.I. FushimiT. ShimuraM. KohdaM. OhtakeA. MurayamaK. OkazakiY. A high mutation load of m.14597A>G in MT-ND6 causes Leigh syndrome.Sci. Rep.20211111112310.1038/s41598‑021‑90196‑534045482
    [Google Scholar]
  25. HaumannS. BoixJ. KnueverJ. BielingA. Vila SanjurjoA. ElsonJ.L. BlakelyE.L. TaylorR.W. RietN. AbkenH. KashkarH. Hornig-DoH.T. WiesnerR.J. Mitochondrial DNA mutations induce mitochondrial biogenesis and increase the tumorigenic potential of Hodgkin and Reed–Sternberg cells.Carcinogenesis202041121735174510.1093/carcin/bgaa03232255484
    [Google Scholar]
  26. SilvaA.M. OliveiraP.J. Evaluation of respiration with clark-type electrode in isolated ,itochondria and permeabilized animal cells.Methods Mol. Biol.2018178272910.1007/978‑1‑4939‑7831‑1_229850992
    [Google Scholar]
  27. DivakaruniA.S. RogersG.W. MurphyA.N. Measuring mitochondrial function in permeabilized cells using the seahorse XF analyzer or a clark-type oxygen electrode.Curr. Protoc. Toxicol.20146011610.1002/0471140856.tx2502s60
    [Google Scholar]
  28. VithayathilS.A. MaY. KaipparettuB.A. Transmitochondrial cybrids: tools for functional studies of mutant mitochondria.Methods Mol. Biol.201283721923010.1007/978‑1‑61779‑504‑6_1522215551
    [Google Scholar]
  29. KingM.P. AttardiG. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.Science1989246492950050310.1126/science.28144772814477
    [Google Scholar]
  30. SazonovaM.A. RyzhkovaA.I. SinyovV.V. GalitsynaE.V. OrekhovaV.A. MelnichenkoA.A. OrekhovA.N. RavaniA.L. SobeninI.A. New markers of atherosclerosis: a threshold level of heteroplasmy in mtDNA mutations.Vessel Plus2017118219110.20517/2574‑1209.2017.16
    [Google Scholar]
  31. SazonovaM.A. SinyovV.V. RyzhkovaA.I. SazonovaM.D. KhasanovaZ.B. SobeninI.A. MtDNA mutations linked with left ventricular hypertrophy.Vessel Plus20192019510.20517/2574‑1209.2018.56
    [Google Scholar]
  32. SobeninI.A. SazonovaM.A. PostnovA.Y. BobryshevY.V. OrekhovA.N. Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta.Clin. Dev. Immunol.201220121510.1155/2012/83246422997526
    [Google Scholar]
  33. OrekhovA.N. NikiforovN.G. OmelchenkoA.V. SinyovV.V. SobeninI.A. VinokurovA.Y. OrekhovaV.A. The role of mitochondrial mutations in chronification of inflammation: hypothesis and overview of own dta.Life (Basel)2022128115310.3390/life1208115336013333
    [Google Scholar]
  34. FinstererJ. Atherosclerosis can be mitochondrial: A review.Cureus2020122e698710.7759/cureus.698732201664
    [Google Scholar]
  35. ČaterM. Križančić BombekL.K. Protective role of mitochondrial uncoupling proteins against age-related oxidative stress in type 2 diabetes mellitus.Antioxidants2022118147310.3390/antiox1108147336009191
    [Google Scholar]
  36. StamerraC.A. Di GiosiaP. GiorginiP. FerriC. SukhorukovV.N. SahebkarA. Mitochondrial dysfunction and cardiovascular disease: pathophysiology and emerging therapies.Oxid. Med. Cell. Longev.2022202211610.1155/2022/953000735958017
    [Google Scholar]
  37. DiMauroS. Pathogenesis and treatment of mitochondrial myopathies: recent advances.Acta Myol.201029233333821314015
    [Google Scholar]
  38. Dubois-DeruyE. PeugnetV. TurkiehA. PinetF. Oxidative stress in cardiovascular diseases.Antioxidants20209986410.3390/antiox909086432937950
    [Google Scholar]
  39. ValléeA. ValléeJ.N. LecarpentierY. Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ.J. Mol. Cell. Cardiol.2019133364610.1016/j.yjmcc.2019.05.02431153873
    [Google Scholar]
  40. Piotrowska-NowakA. ElsonJ.L. Sobczyk-KopciolA. PiwonskaA. Puch-WalczakA. DrygasW. PloskiR. BartnikE. TonskaK. New mtDNA association model, MutPred variant load, suggests individuals with multiple mildly deleterious mtDNA variants are more likely to suffer from atherosclerosis.Front. Genet.2019970210.3389/fgene.2018.0070230671084
    [Google Scholar]
  41. MaltepeE. SaugstadO.D. Oxygen in health and disease: regulation of oxygen homeostasis-clinical implications.Pediatr. Res.200965326126810.1203/PDR.0b013e31818fc83f18852690
    [Google Scholar]
  42. TretterV. ZachM.L. BöhmeS. UllrichR. MarkstallerK. KleinK.U. Investigating disturbances of pxygen homeostasis: from cellular mechanisms to the clinical practice.Front. Physiol.20201194710.3389/fphys.2020.0094732848874
    [Google Scholar]
  43. D’AurelioM. GajewskiC.D. LenazG. ManfrediG. Respiratory chain supercomplexes set the threshold for respiration defects in human mtDNA mutant cybrids.Hum. Mol. Genet.200615132157216910.1093/hmg/ddl14116740593
    [Google Scholar]
  44. RugoloM. ZannaC. GhelliA.M. Organization of the respiratory supercomplexes in cells with defective complex III: structural features and metabolic consequences.Life (Basel)202111435110.3390/life1104035133920624
    [Google Scholar]
  45. FormosaL.E. Muellner-WongL. ReljicB. SharpeA.J. JacksonT.D. BeilharzT.H. StojanovskiD. LazarouM. StroudD.A. RyanM.T. Dissecting the roles of mitochondrial complex I intermediate assembly complex factors in the biogenesis of complex I.Cell Rep.202031310754110.1016/j.celrep.2020.10754132320651
    [Google Scholar]
  46. Marco-BruallaJ. Al-WasabyS. SolerR. RomanosE. CondeB. Justo-MéndezR. EnríquezJ.A. Fernández-SilvaP. Martínez-LostaoL. VillalbaM. Moreno-LoshuertosR. AnelA. Mutations in the ND2 subunit of mitochondrial complex I are sufficient to confer increased tumorigenic and metastatic potential to cancer cells.Cancers (Basel)2019117102710.3390/cancers1107102731330915
    [Google Scholar]
  47. ProtasoniM. Pérez-PérezR. Lobo-JarneT. HarbourM.E. DingS. PeñasA. DiazF. MoraesC.T. FearnleyI.M. ZevianiM. UgaldeC. Fernández-VizarraE. Respiratory supercomplexes act as a platform for complex III -mediated maturation of human mitochondrial complexes I and IV.EMBO J.2020393e10281710.15252/embj.201910281731912925
    [Google Scholar]
  48. RanaD. BagK. BhattacharyyaS.N. MandalB.M. Miscibility of poly(styrene-co-butyl acrylate) with poly(ethyl methacrylate): Existence of both UCST and LCST.J. Polym. Sci., B, Polym. Phys.200038336937510.1002/(SICI)1099‑0488(20000201)38:3<369::AID‑POLB3>3.0.CO;2‑W
    [Google Scholar]
  49. RanaD. MandalB.M. BhattacharyyaS.N. Miscibility and phase diagrams of poly(phenyl acrylate) and poly(styrene-co-acrylonitrile) blends.Polymer (Guildf.)19933471454145910.1016/0032‑3861(93)90861‑4
    [Google Scholar]
  50. RanaD. MandalB.M. BhattacharyyaS.N. Analogue calorimetry of polymer blends: poly(styrene-co-acrylonitrile) and poly(phenyl acrylate) or poly(vinyl benzoate).Polymer199637122439244310.1016/0032‑3861(96)85356‑0
    [Google Scholar]
  51. RanaD. MandalB.M. BhattacharyyaS.N. Analogue calorimetric studies of blends of poly(vinyl ester)s and polyacrylates.Macromolecules19962951579158310.1021/ma950954n
    [Google Scholar]
  52. DemineS. RenardP. ArnouldT. Mitochondrial uncoupling: a key controller of biological processes in physiology and diseases.Cells20198879510.3390/cells808079531366145
    [Google Scholar]
  53. BonoraM. WieckowskiM.R. SinclairD.A. KroemerG. PintonP. GalluzziL. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.Nat. Rev. Cardiol.2019161335510.1038/s41569‑018‑0074‑030177752
    [Google Scholar]
  54. DaiD.F. ChenT. SzetoH. Nieves-CintrónM. KutyavinV. SantanaL.F. RabinovitchP.S. Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.J. Am. Coll. Cardiol.2011581738210.1016/j.jacc.2010.12.04421620606
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673302002240605092523
Loading
/content/journals/cmc/10.2174/0109298673302002240605092523
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test